Navigation Links
HIV Drug Tenofovir Safe During Pregnancy, Study Suggests
Date:5/3/2012

THURSDAY, May 3 (HealthDay News) -- The use of the anti-HIV drug tenofovir during pregnancy appears to be safe for infants, new research suggests.

In combination with other anti-HIV drugs, tenofovir (Viread) is the first line of treatment for adults with HIV, the virus that causes AIDS. These findings should reassure pregnant women who are taking tenofovir, the researchers said.

The study was conducted by the U.S. National Institutes of Health network because previous studies showed that laboratory animals exposed to tenofovir in the womb were smaller at birth than those that were not exposed to the drug.

The new study included 2,000 infants born to HIV-positive mothers between 2003 and 2010 in the United States. Infants born to mothers who took tenofovir during pregnancy did not weigh less at birth and did not have shorter length than those born to women who did not take the drug.

At 1 year of age, however, children born to mothers who took tenofovir during pregnancy were slightly shorter and had slightly smaller head circumference (an average of about 1 centimeter) than children whose mothers did not take the drug, the investigators found.

The researchers said further studies should be conducted to follow the children as they grow and develop in order to identify any potential long-term effects of taking tenofovir during pregnancy.

The study was released online April 26 in advance of publication in an upcoming print issue of the journal AIDS.

"This study produced reassuring information regarding the use of tenofovir," first author Dr. George Siberry, of the Pediatric, Adolescent and Maternal AIDS Branch of the U.S. National Institute of Child Health and Human Development, said in a National Institutes of Health news release.

"Although further research is needed ... our findings favor the use of tenofovir in pregnancy to ensure good outcomes in the mother and prevent transmission of HIV to the infant," Siberry added.

More information

The New Mexico AIDS Education and Training Center has more about HIV and pregnancy.

-- Robert Preidt

SOURCE: U.S. National Institute of Child Health and Human Development, news release, May 1, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Tenofovir gel dropped from HIV prevention trial in women because it was not effective
2. Major HIV prevention trial in women to drop oral tenofovir arm
3. Next steps for Tenofovir gel: CONRAD and TIA sign license agreement
4. Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue
5. Tenofovir gel provides high level of protection against HIV in rectal tissue
6. Promising HIV prevention microbicide tenofovir gel being tested for safety of rectal use
7. Heroin Addicts Have Higher Pain Sensitivity, Even During Treatment
8. Presidential Recognition Awards presented during the 2012 AIUM Annual Convention
9. Exercise improves quality of life during breast cancer treatment
10. Few young women with cancer take steps to preserve fertility during treatments
11. Use of anesthesia providers during GI procedures is growing, but may be unnecessary
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
HIV Drug Tenofovir Safe During Pregnancy, Study Suggests
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the ... medical article to the newly revamped Cosmetic Town journal section, featuring ... transplant procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
Breaking Medicine Technology: